Guangdong Taiantang Pharmaceutical Co.,Ltd. Posted 109.4 Million Yuan Net Loss in First Half of 2023

Guangdong Taiantang Pharmaceutical Co.,Ltd. (广东太安堂药业股份有限公司) (002433.SZ) reported a net loss of 109.4 million yuan in the first half of 2023, narrowing 15.3% year-on-year.

Meanwhile, the company posted 261.1 million yuan in revenue, down 48.8% year-on-year.

At the end of the reporting period, it had 6.3 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 42.8%.